Revised ABN guidelines published

23 December 2009

At long last the new Association of British Neurologists (ABN) revised (2009) guidelines for prescribing disease modifying drugs in multiple sclerosis have been published.

The original ABN guidelines were published in 2001. The revised guidelines incorporate advances in treatment since then. They lay out clearly a strategy for treating people with MS with drug therapies that supports the concept of the Department of Health Risk-sharing Scheme, and the need for people to be referred to a neurologist with special expertise in MS. They also support the role of the MS specialist nurse in managing symptoms as well as providing information and reassurance to patients on treatment during and between clinic attendance.